Title of article
Controlled drug delivery in tissue engineering
Author/Authors
Biondi، نويسنده , , Marco and Ungaro، نويسنده , , Francesca and Quaglia، نويسنده , , Fabiana and Netti، نويسنده , , Paolo Antonio، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
14
From page
229
To page
242
Abstract
The concept of tissue and cell guidance is rapidly evolving as more information regarding the effect of the microenvironment on cellular function and tissue morphogenesis become available. These disclosures have lead to a tremendous advancement in the design of a new generation of multifunctional biomaterials able to mimic the molecular regulatory characteristics and the three-dimensional architecture of the native extracellular matrix. Micro- and nano-structured scaffolds able to sequester and deliver in a highly specific manner biomolecular moieties have already been proved to be effective in bone repairing, in guiding functional angiogenesis and in controlling stem cell differentiation. Although these platforms represent a first attempt to mimic the complex temporal and spatial microenvironment presented in vivo, an increased symbiosis of material engineering, drug delivery technology and cell and molecular biology may ultimately lead to biomaterials that encode the necessary signals to guide and control developmental process in tissue- and organ-specific differentiation and morphogenesis.
Keywords
CASD , PA , PTH , delivery systems , Poly(?-caprolactone) , Solid free-form fabrication , DS , PCL , SFF , ECM , PDGF , TE , computer-aided scaffold design , Peptide amphiphile , Parathyroid Hormone , Extracellular matrix , Platelet derived growth factor , Tissue engineering , Bone morphogenetic protein , heparin-based delivery systems , Poly(lactide-co-glycolide) , Growth factors , BMP , HBDS , PLGA , Biomaterials , basic fibroblast growth factor , Growth factor , Poly(lactide) , DRUG DELIVERY , BSA , NT-3 , POE , Scaffold , EVAc , PEO , VEGF , bFGF , GF , PLA , Tissue engineering , EGF , PEG , TGF-?1 , Bovine serum albumin , neurotrophin-3 , Poly(ortho esters) , Ethylene-vinyl acetate copolymers , Poly(ethylene oxide) , Vascular endothelial growth factor , Epidermal Growth Factor , Poly(ethylene glycol) , Transforming growth factor-beta1
Journal title
Advanced Drug Delivery Reviews
Serial Year
2008
Journal title
Advanced Drug Delivery Reviews
Record number
1762226
Link To Document